Cytokine and autoantibody profiling related to histopathological features in primary Sjögren's syndrome

Rheumatology

Volumn 48, Issue 9, 2009, Pages 1102-1106

  Reksten, Tove R ^a   Jonsson, Malin V ^a,b   Szyszko, Ewa A ^a   Brun, Johan G ^b,c   Jonsson, Roland ^a,c   Brokstad, Karl A ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Adiopocytes; Atrophy; Autoantibodies; Cytokines; Degenerative changes; Fibrosis; Inflammation; Salivary glands

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; CHEMOKINE; CYTOKINE; EOTAXIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; AUTOANTIGEN; RIBONUCLEOPROTEIN; SMALL CYTOPLASMIC RNA; SS A ANTIGEN; SS B ANTIGEN; SS-A ANTIGEN; SS-B ANTIGEN; TROVE2 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD LEVEL; CELL INFILTRATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; GERMINAL CENTER; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MINOR SALIVA GLAND; MONONUCLEAR CELL; PRIORITY JOURNAL; SALIVARY GLAND; SALIVARY GLAND BIOPSY; SALIVATION; SJOEGREN SYNDROME; AGE; BIOPSY; BLOOD; COHORT ANALYSIS; IMMUNOLOGY; MIDDLE AGED; ONSET AGE; PATHOLOGY;

ADULT; AGE FACTORS; AGE OF ONSET; AUTOANTIBODIES; AUTOANTIGENS; BIOPSY; COHORT STUDIES; CYTOKINES; GERMINAL CENTER; HUMANS; MIDDLE AGED; RIBONUCLEOPROTEINS; RNA, SMALL CYTOPLASMIC; SALIVARY GLANDS, MINOR; SJOGREN'S SYNDROME;

EID: 70349785865     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep149     Document Type: Article

References (23)

1. Jonsson R, Bowman S, Gordon TP. Sjögren. In: Koopman WJ, Moreland LW, eds. Arthritis and allied conditions -a textbook of rheumatology, 15th edn. Philadelphia: Lippincott Williams and Wilkins, 2005;1681-705.
2. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
3. Jonsson R, Kroneld U, Bäckman K, Magnusson B, Tarkowski A. Progression of sialadenitis in Sjögren's syndrome. Br J Rheumatol 1993;32:578-81.
4. Humphreys-Beher MG, Brayer J, Yamachika S, Peck AB, Jonsson R. An alternative perspective to the immune response in autoimmune exocrinopathy: induction of functional quiescence rather than destructive autoaggression. Scand J Immunol 1999;49:7-10.
5. Stott DI, Hiepe F, Hummel M, Steinhauser G, Berek C. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjögren's syndrome. J Clin Invest 1998;102:938-46.
6. Salomonsson S, Jonsson MV, Skarstein K et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis Rheum 2003;48:3187-201.
7. Jonsson MV, Skarstein K, Jonsson R, Brun JG. Serological implications of germinal center-like structures in primary Sjögren's syndrome. J Rheumatol 2007;34:2044-9.
8. Le Pottier L, Devauchelle V, Fautrel A et al. Ectopic germinal centers are rare in Sjögren's syndrome salivary glands and do not exclude autoreactive B cells. J Immunol 2009;182:3540-7.
9. Garcia-Carrasco M, Font J, Filella X et al. Circulating levels of Th1/Th2 cytokines in patients with primary Sjögren's syndrome: correlation with clinical and immunological features. Clin Exp Rheumatol 2001;19:411-5.
10. Nguyen CQ, Hu MH, Li Y, Stewart C, Peck AB. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome. Arthritis Rheum 2008;58:734-3.
11. Garberg H, Jonsson R, Brokstad KA. The serological pattern of autoantibodies to the Ro52, Ro60, and La48 autoantigens in primary Sjögren's syndrome patients and healthy controls. Scand J Rheumatol 2005;34:49-55.
12. Haga HJ, Jonsson R. The influence of age on disease manifestations and serological characteristics in primary Sjögren's syndrome. Scand J Rheumatol 1999;28:227-32.
13. Wahren M, Tengner P, Gunnarsson I et al. Ro/SS-A and La/SS-B antibody level variation in patients with Sjögren's syndrome and systemic lupus erythematosus. J Autoimmun 1998;11:29-38.
14. Amft N, Curnow SJ, Scheel-Toellner D et al. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome. Arthritis Rheum 2001;44:2633-41.
15. Liew FY, McInnes IB. Role of interleukin 15 and interleukin 18 in inflammatory response. Ann Rheum Dis 2002;61:ii100-2.
16. Bessis N, Boissier M-C. Novel pro-inflammatory interleukins: potential therapeutic targets in rheumatoid arthritis. Joint Bone Spine 2001;68:477-81.
17. Theofilopoulos AN, Baccala R, Beutler B, Kono DH. Type I interferons (α/β) in immunity and autoimmunity. Ann Rev Immunol 2005;23:307-35.
18. Båve U, Nordmark G, Lövgren T et al. Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism. Arthritis Rheum 2005;52:1185-95.
19. Hjelmervik TOR, Petersen K, Jonassen I, Jonsson R, Bolstad AI. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects. Arthritis Rheum 2005;52:1534-44.
20. Bettelli E, Oukka M, Kuchroo VK. TH-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007;8:345-50.
21. Wilson NJ, Boniface K, Chan JR et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007;8:950-7.
22. Benjamin E, Coico R, Sunshine G. Cytokines. Immunology: a short course, 4th edn. New York: Wiley-Liss, Inc., 2000.
23. Gao J, Killedar S, Cornelius JG, Nguyen C, Cha S, Peck AB. Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease. J Autoimmun 2006;26:90-103.